Literature DB >> 7967502

Macrophages and renal disease.

H Van Goor1, G Ding, D Kees-Folts, J Grond, G F Schreiner, J R Diamond.   

Abstract

In this multimodel overview, we have provided the seminal experimental evidence for the crucial contribution of macrophages in the progression of glomerular and interstitial fibrosis. Although all the experimental data provided in this review definitely increase our understanding of the progress of renal disease, we have been mindful to use caution in extrapolating data from animal experiments to the clinical setting (109). In addition, uncertainty still exists as to whether macrophages activation entails a generalized mechanism in which the cells release growth factors and other mediators such as bioactive lipids and nitric oxide simultaneously, or a selective mechanism in which the cells release some but not all macrophage products (110). However, we anticipate that further substantial clinical and experimental observations are on the horizon. Novel therapeutic strategies in these models must be concerned with the prevention of renal macrophage recruitment and/or the suppression of the fibrogenic ability of this pluripotential inflammatory cell.

Entities:  

Mesh:

Year:  1994        PMID: 7967502

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

Authors:  G Wolf; F N Ziyadeh; F Thaiss; J Tomaszewski; R J Caron; U Wenzel; G Zahner; U Helmchen; R A Stahl
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

Authors:  Masashi Nishida; Hidehiko Fujinaka; Taiji Matsusaka; James Price; Valentina Kon; Agnes B Fogo; Jeffrey M Davidson; MacRae F Linton; Sergio Fazio; Toshio Homma; Hiroaki Yoshida; Iekuni Ichikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 4.  Extracellular matrix and the kidney.

Authors:  P N Furness
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 5.  Macrophages and immunologic inflammation of the kidney.

Authors:  Jeremy S Duffield
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

6.  HIV-1 gp160 protein-macrophage interactions modulate mesangial cell proliferation and matrix synthesis.

Authors:  P C Singhal; P Sharma; P Garg
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

7.  Low-density lipoproteins enhance transforming growth factor-beta 1 (TGF-beta 1) and monocyte chemotactic protein-1 (MCP-1) expression induced by cyclosporin in human mesangial cells.

Authors:  S Di Paolo; G Grandaliano; L Gesualdo; E Ranieri; F P Schena
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

8.  Morphine stimulates mesangial cell TNF-alpha and nitrite production.

Authors:  A A Kapasi; N Gibbons; J Mattana; P C Singhal
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

9.  Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.

Authors:  Thian Kui Tan; Guoping Zheng; Tzu-Ting Hsu; Ying Wang; Vincent W S Lee; Xinrui Tian; Yiping Wang; Qi Cao; Ya Wang; David C H Harris
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

10.  Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents.

Authors:  Peter J Wermuth; Francesco Del Galdo; Sergio A Jiménez
Journal:  Arthritis Rheum       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.